Table 4 Mean Change for Q-LES-Q SF percentage maximum scores from baseline to 6 weeks: adjunctive therapy (Lurasidone 20–120 mg/day and Placebo)
|  | Lurasidone 20–120 mg/day | Placebo | ||||
|---|---|---|---|---|---|---|
| Â | N Mean (SD) | N Mean Change (SD) | P value | N Mean (SD) | N Mean Change (SD) | P value |
Q-LES-Q SF | Â | Â | Â | Â | Â | Â |
Baseline | 177 36.1 (14.3) | -- | Â | 159 35.7 (13.5) | -- | Â |
6-Weeks | 142 58.4 (181) | 141 23.3 (18.7) | <.0001 | 135 52.7 (19.9) | 134 17.9 (20.2) | <.0001 |